Corresponding Author: Isobel M. Pye, MD, BMed, Royal North Shore Hospital, Reserve Road, St Leonards NSW 2065, Australia (firstname.lastname@example.org).
Published Online: November 30, 2022. doi:10.1001/jamadermatol.2022.4550
Conflict of Interest Disclosures: Dr Saw reported personal fees from Novartis, MSD, Qbiotics, and BMS outside the submitted work. No other disclosures were reported.
Additional Contributions: We thank the patient for granting permission to publish this information.
FL , Ten Eikelder
MLG , van Geloven
et al. Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice. Gynecol Oncol
. 2021;161(1):202-210.PubMedGoogle ScholarCrossref
DN , Yu
GP , McCormick
SA . Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas. Melanoma Res
. 2010;20(2):153-158.PubMedGoogle ScholarCrossref
V , Gori
A , Salvati
et al. Clinical and dermoscopic features of vulvar melanosis over the last 20 years. JAMA Dermatol
. 2020;156(11):1185-1191.PubMedGoogle ScholarCrossref